MCG as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction

Clinical trial NCT05150054 · COMPLETED

Trial details

NCT number: NCT05150054
Sponsor: Genetesis Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Coronary Microvascular Dysfunction Ischemic Non-Obstructive Coronary Artery Disease

Start date: 2022-01-14
Primary completion: 2023-07-18
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.